Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HtrA serine peptidase 1 | 0.532 | 0.692 | 4.9E-04 |
|
disease | 0.410 | strong | 1.000 | 0 | 1 | 2014 | 2015 | ||||||||
|
nectin cell adhesion molecule 2 | 0.575 | 0.769 | 0.97 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2018 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.200 | None | 1.000 | 0 | 0 | 2012 | 2019 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.200 | None | 0.917 | 0 | 0 | 2013 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 1 | 0.477 | 0.808 | 1.00 |
|
disease | 0.200 | None | 1.000 | 0 | 0 | 2001 | 2019 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.200 | None | 0.989 | 0 | 0 | 2006 | 2020 | ||||||||
|
dystrophin | 0.423 | 0.923 | 1.00 |
|
disease | 0.200 | None | 0.857 | 0 | 0 | 1994 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.190 | None | 1.000 | 0 | 0 | 2011 | 2020 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
disease | 0.190 | None | 1.000 | 0 | 1 | 2015 | 2020 | ||||||||
|
insulin receptor | 0.432 | 0.846 | 3.6E-05 |
|
disease | 0.180 | None | 1.000 | 0 | 0 | 2005 | 2020 | ||||||||
|
spastin | 0.579 | 0.577 | 1.00 |
|
disease | 0.170 | None | 1.000 | 0 | 0 | 2000 | 2018 | ||||||||
|
glial cell derived neurotrophic factor | 0.434 | 0.885 | 0.20 |
|
disease | 0.150 | None | 1.000 | 0 | 0 | 2017 | 2019 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
disease | 0.150 | None | 1.000 | 0 | 0 | 2014 | 2019 | ||||||||
|
SPG11 vesicle trafficking associated, spatacsin | 0.576 | 0.538 | 1.6E-39 |
|
disease | 0.150 | None | 1.000 | 0 | 0 | 1999 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily Q member 2 | 0.537 | 0.654 | 1.00 |
|
disease | 0.140 | None | 1.000 | 0 | 0 | 2013 | 2018 | ||||||||
|
spectrin beta, non-erythrocytic 2 | 0.619 | 0.731 | 9.9E-05 |
|
disease | 0.140 | None | 0.750 | 0 | 0 | 2012 | 2020 | ||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
disease | 0.140 | None | 1.000 | 0 | 1 | 2017 | 2019 | ||||||||
|
Coenzyme A synthase | 0.551 | 0.654 | 8.1E-10 |
|
disease | 0.140 | None | 1.000 | 0 | 0 | 2010 | 2019 | ||||||||
|
CD36 molecule | 0.446 | 0.846 | 1.1E-60 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2012 | 2017 | ||||||||
|
ATPase cation transporting 13A2 | 0.566 | 0.577 | 9.0E-09 |
|
disease | 0.130 | None | 1.000 | 0 | 0 | 2011 | 2014 | ||||||||
|
PPARG coactivator 1 alpha | 0.453 | 0.885 | 1.00 |
|
disease | 0.120 | None | 1.000 | 1 | 2 | 2015 | 2018 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2009 | 2018 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2018 | 2018 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2011 | 2019 | ||||||||
|
complement factor H | 0.441 | 0.885 | 0.86 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2011 | 2018 |